Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Guilong Guo
Observed names:
G. Guo,
Guo, Guilong
Institution:
First Affiliated Hospital of Wenzhou Medical University
Observed institution:
First Affiliated Hospital of Wenzhou Medical University
ORCID:
0000-0002-6390-1610
Observed ORCID:
0000-0002-6390-1610
OpenAlex ID:
A5089916652
Suppression of MD2 inhibits breast cancer in vitro and in vivo
2021
·
S. Zheng
, W. Fu
, et al.
·
Clinical & Translational Oncology
·
8
PDF
Breast metastasis from lung adenocarcinoma: a case report and review of the literature
2024
·
Jialing Ding
, Huayan Gu
, et al.
·
Frontiers in Oncology
·
5
Breast implant-associated anaplastic large cell lymphoma: a case report and literature review
2026
·
Shuangyi Qi
, Hu Liu
, et al.
·
Frontiers in Oncology
PDF
Neoadjuvant pyrotinib and inetetamab in combination with chemotherapy for locally advanced HER2-positive breast cancer (NeoPICD study): A prospective, multicenter, open-label, single-arm study.
2024
·
Yiying Xu
, Xue Wu
, et al.
·
Journal of Clinical Oncology
The population characteristic analysis in RecurIndex for clinical decision-making on adjuvant therapy for early breast cancer: Results of a real-world study.
2022
·
Xiaojia Wang
, Lei Lei
, et al.
·
Journal of Clinical Oncology
Additional file 1: Figure S1. of (S)-crizotinib induces apoptosis in human non-small cell lung cancer cells by activating ROS independent of MTH1
2017
·
Dai, Xuanxuan
, Guo, Guilong
, et al.
·
Figshare
Show more works
View as search
Works count:
6
Citation count:
13
H-index:
2
I10-index:
Year
Topic
Type